These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Twelve-month persistency of a novel ribose-cross-linked collagen dermal filler. Narins RS; Brandt FS; Lorenc ZP; Maas CS; Monheit GD; Smith SR Dermatol Surg; 2008 Jun; 34 Suppl 1():S31-9. PubMed ID: 18547179 [TBL] [Abstract][Full Text] [Related]
24. Advantages of the presence of living dermal fibroblasts within restylane for soft tissue augmentation. Yoon ES; Han SK; Kim WK Ann Plast Surg; 2003 Dec; 51(6):587-92. PubMed ID: 14646655 [TBL] [Abstract][Full Text] [Related]
25. Hyaluronic acid gel in skin rejuvenation. Carruthers J; Carruthers A J Drugs Dermatol; 2006; 5(10):959-64. PubMed ID: 17373144 [TBL] [Abstract][Full Text] [Related]
26. Evaluation of the safety of a non-animal stabilized hyaluronic acid (NASHA -- Q-Medical, Sweden) in European countries: a retrospective study from 1997 to 2001. André P J Eur Acad Dermatol Venereol; 2004 Jul; 18(4):422-5. PubMed ID: 15196154 [TBL] [Abstract][Full Text] [Related]
27. Evaluation of a calcium hydroxylapatite-based implant (Radiesse) for facial soft-tissue augmentation. Jansen DA; Graivier MH Plast Reconstr Surg; 2006 Sep; 118(3 Suppl):22S-30S, discussion 31S-33S. PubMed ID: 16936541 [TBL] [Abstract][Full Text] [Related]
28. Understanding the anatomy when using dermal fillers enhances patient safety. Hotta T Plast Surg Nurs; 2006; 26(3):149-51. PubMed ID: 16990754 [No Abstract] [Full Text] [Related]
29. Multidose of restylane for facial augmentation. Emilson A; Johansson C; Wong C Arch Facial Plast Surg; 2010; 12(6):433; author reply 433-4. PubMed ID: 21079125 [No Abstract] [Full Text] [Related]
30. Randomized, evaluator-blind, split-face comparison study of single cross-linked versus double cross-linked hyaluronic acid in the treatment of glabellar lines. Kono T; Kinney BM; Groff WF; Chan HH; Ercocen AR; Nozaki M Dermatol Surg; 2008 Jun; 34 Suppl 1():S25-30. PubMed ID: 18547178 [TBL] [Abstract][Full Text] [Related]
31. The long-term efficacy and safety of a subcutaneously injected large-particle stabilized hyaluronic acid-based gel of nonanimal origin in esthetic facial contouring. DeLorenzi C; Weinberg M; Solish N; Swift A Dermatol Surg; 2009 Feb; 35 Suppl 1():313-21. PubMed ID: 19207320 [TBL] [Abstract][Full Text] [Related]
32. Dermal fillers. Med Lett Drugs Ther; 2007 May; 49(1260):39-40. PubMed ID: 17483790 [No Abstract] [Full Text] [Related]
33. Persistence and improvement of nasolabial fold correction with nonanimal-stabilized hyaluronic acid 100,000 gel particles/mL filler on two retreatment schedules: results up to 18 months on two retreatment schedules. Narins RS; Dayan SH; Brandt FS; Baldwin EK Dermatol Surg; 2008 Jun; 34 Suppl 1():S2-8; discussion S8. PubMed ID: 18547177 [TBL] [Abstract][Full Text] [Related]
37. Effect of injection techniques on the rate of local adverse events in patients implanted with nonanimal hyaluronic acid gel dermal fillers. Glogau RG; Kane MA Dermatol Surg; 2008 Jun; 34 Suppl 1():S105-9. PubMed ID: 18547173 [TBL] [Abstract][Full Text] [Related]
38. A prospective, rater-blind, randomized comparison of the effectiveness and tolerability of Belotero ® Basic versus Restylane ® for correction of nasolabial folds. Prager W; Steinkraus V Eur J Dermatol; 2010; 20(6):748-52. PubMed ID: 20974558 [TBL] [Abstract][Full Text] [Related]
39. Science of Hyaluronic Acid Beyond Filling: Fibroblasts and Their Response to the Extracellular Matrix. Landau M; Fagien S Plast Reconstr Surg; 2015 Nov; 136(5 Suppl):188S-195S. PubMed ID: 26441098 [TBL] [Abstract][Full Text] [Related]